Strides Pharma Science Ltd reported a consolidated net profit of Rs 93.66 crore for the second quarter of FY25, recovering from a Rs 149.45 crore net loss in the same period last fiscal. Revenue rose to Rs 1,201.11 crore, driven by new product launches and significant growth in US operations.
| Subscribe To Our Free Newsletter |
